Glycerol

IBSA USA Renews Partnership With Professional Golfer Aza Muñoz to Promote Tirosint®-SOL

Retrieved on: 
화요일, 6월 4, 2024

IBSA USA has renewed its partnership with professional golfer Azahara (Aza) Muñoz to promote Tirosint®-SOL (levothyroxine sodium) oral solution, a unique liquid hypothyroidism treatment, through the 2025 golf season.

Key Points: 
  • IBSA USA has renewed its partnership with professional golfer Azahara (Aza) Muñoz to promote Tirosint®-SOL (levothyroxine sodium) oral solution, a unique liquid hypothyroidism treatment, through the 2025 golf season.
  • Muñoz, who has Hashimoto’s thyroiditis that results in hypothyroidism, has found relief since she began taking Tirosint-SOL and regained control over her hypothyroid symptoms.
  • She attributes her restored energy and improved symptom relief to this innovative treatment option.
  • I’ve experienced significant improvements in my energy levels and overall well-being,” said Muñoz.

Global Glycerol Monostearate Industry Report 2024: $2.09 Billion Market Analysis by Purity, Type, Application & Region 2023-2029 - ResearchAndMarkets.com

Retrieved on: 
화요일, 5월 21, 2024

The "Global Glycerol Monostearate Market: Analysis By Purity, By Type, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Glycerol Monostearate Market: Analysis By Purity, By Type, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.
  • In 2023, the global glycerol monostearate (GMS) market was valued at US$1.63 billion, and is probable to reach US$2.09 billion by 2029.
  • The global glycerol monostearate (GMS) market value is projected to grow at a CAGR of 4.22%, during the forecast period of 2024-2029.
  • Asia Pacific glycerol monostearate (GMS) market enjoyed the highest market share in 2023, as glycerol monostearate (GMS) finds extensive application across various sectors in Asia Pacific, including pharmaceuticals, textiles, and paints & coatings.

SkinCeuticals Announces the Launch of Clear Daily Soothing UV Defense SPF 50

Retrieved on: 
수요일, 5월 1, 2024

NEW YORK, May 1, 2024 /PRNewswire/ -- SkinCeuticals, the #1 Medical Skincare Brand, announces the launch of Clear Daily Soothing UV Defense SPF 50, a transparent, non-comedogenic daily-use sunscreen. This new hybrid-blend SPF offers a potent blend of protection, hydration, and soothing benefits with a cast-free, blendable finish, tested across all skin tones.

Key Points: 
  • NEW YORK, May 1, 2024 /PRNewswire/ -- SkinCeuticals, the #1 Medical Skincare Brand, announces the launch of Clear Daily Soothing UV Defense SPF 50, a transparent, non-comedogenic daily-use sunscreen.
  • SkinCeuticals Clear Daily Soothing UV Defense SPF 50 targets sensitive skin, the leading category of the photoprotection market.1 UV exposure worsens sensitive skin symptoms through inflammation by initiating the inflammation cascade, triggering the over production of pro-inflammatory mediators and increasing symptoms of sensitivity, thus worsening skin redness and breakouts.
  • Clear Daily Soothing UV Defense SPF 50 addresses this issue by offering a comprehensive defense against UV exposure, helping to minimize symptoms such as redness, dryness, and discomfort.
  • Clear Daily Soothing UV Defense SPF 50 boasts a thorough dossier of clinical testing to demonstrate its efficacy.

Brooks Running Sets Competitive Pace in Q1 with Record Quarterly Revenue

Retrieved on: 
목요일, 5월 2, 2024

Brooks Running achieved record revenue in the first quarter of 2024, up 9% year over year and representing the highest quarterly results in the brand’s history.

Key Points: 
  • Brooks Running achieved record revenue in the first quarter of 2024, up 9% year over year and representing the highest quarterly results in the brand’s history.
  • Brooks’ global e-commerce business was up 22% in the first quarter compared to Q1 2023, with 38% year-over-year growth in March alone.
  • “Brooks’ runner-first strategy and execution continue to drive success for our brand on a global scale,” said Dan Sheridan, Brooks CEO.
  • This is what sets Brooks apart.”
    Brooks maintained its pace of innovation across footwear and apparel categories this quarter in what will be a record year for product introduction.

La Roche-Posay Expands Best-Selling Healing Cicaplast Collection with Cicaplast Gel B5 Skin Protectant and Cicaplast Lips Hydration Restore Lip Balm

Retrieved on: 
월요일, 4월 8, 2024

Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.

Key Points: 
  • Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.
  • Formulated with Vitamin B5 (Panthenol), sustainably sourced Shea Butter and La Roche-Posay Thermal Spring Water, CICAPLAST LIPS HYDRATION RESTORE LIP BALM restores the skin's hydrolipidic film and helps soothe skin.
  • Now, with the launch of CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT, La Roche-Posay is proud to continue to expand its best-selling and healing CICAPLAST collection.
  • CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT are:

Onoxa Unveils Three Cutting-Edge Private Label Skincare Innovations, Redefining The Beauty Entrepreneurship Landscape

Retrieved on: 
금요일, 3월 22, 2024

Onoxa's dedication to innovation and quality shines through in each of these exceptional skincare products, providing aspiring beauty entrepreneurs with unparalleled opportunities to thrive in the competitive market landscape.

Key Points: 
  • Onoxa's dedication to innovation and quality shines through in each of these exceptional skincare products, providing aspiring beauty entrepreneurs with unparalleled opportunities to thrive in the competitive market landscape.
  • Test the products, then begin the launch process of one's own skincare brand by collaborating with Onoxa's expert designers for complimentary label creation.
  • As pioneers in the industry, Onoxa is dedicated to empowering individuals to realize their beauty vision with confidence and ease.
  • Whether one is just starting out or looking to expand, Onoxa is here to help every step of the way.

Skincare Brand PRAI Beauty Announces The Launch Of Its PRAI Pro Line On QVC!

Retrieved on: 
수요일, 3월 20, 2024

NAPLES, Fla., March 20, 2024 /PRNewswire-PRWeb/ -- In the realm of skincare, PRAI Beauty stands out as a true expert with a devoted following and is particularly known for its focus on rejuvenating often overlooked areas like the neck, decolletage, arms and hands. Now, PRAI Beauty proudly introduces its latest creation, PRAI Pro range of skincare, set to debut on QVC on March 19th.

Key Points: 
  • Now, PRAI Beauty proudly introduces its latest creation, PRAI Pro range of skincare, set to debut on QVC on March 19th.
  • PRAI Beauty's PRAI Pro is not your average skincare line, it's a breath of fresh air in QVC Clean Beauty, delivering advanced skin and neck care.
  • Perfect for skincare enthusiasts seeking ingredients without compromising results, the PRAI Pro line contains advanced formulas.
  • Launching exclusively on QVC and the PRAI Beauty website on March 19th, the PRAI Pro line raises the bar for skincare, meeting QVC's Clean Beauty standards.

Herbal medicinal product: Thymi herba and Primulae radixArray, C: ongoing call for scientific data

Retrieved on: 
화요일, 3월 12, 2024

Herbal medicinal product: Thymi herba and Primulae radixArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Thymi herba and Primulae radixArray, C: ongoing call for scientific data

Food And Drug Administration Grants Two New Label Changes To Tirosint®-Sol (Levothyroxine Sodium) Oral Solution

Retrieved on: 
월요일, 12월 4, 2023

The U.S. Food and Drug Administration (FDA) has approved two new changes to the label of Tirosint-SOL (levothyroxine sodium) oral solution, a unique formulation of levothyroxine (LT4) for the treatment of hypothyroidism.

Key Points: 
  • The U.S. Food and Drug Administration (FDA) has approved two new changes to the label of Tirosint-SOL (levothyroxine sodium) oral solution, a unique formulation of levothyroxine (LT4) for the treatment of hypothyroidism.
  • The first regards the use of Tirosint-SOL in the presence of proton pump inhibitor (PPI) therapy.
  • Both label changes help to differentiate Tirosint-SOL from other levothyroxine therapies.
  • Similarly, current labeling for all levothyroxine sodium therapies instructs patients to self-administer the drug once daily, on an empty stomach, one-half to one hour before breakfast.

Get Glowing: Theraderm Unveils the Hottest Night Cream with Retinol and Peptides

Retrieved on: 
목요일, 11월 30, 2023

, Nov. 30, 2023 /PRNewswire/ -- Theraderm Clinical Skincare , a revered leader in skincare innovation, is thrilled to unveil the latest addition to its product range: the Brilliance Night Boost Retinol Repair Cream .

Key Points: 
  • , Nov. 30, 2023 /PRNewswire/ -- Theraderm Clinical Skincare , a revered leader in skincare innovation, is thrilled to unveil the latest addition to its product range: the Brilliance Night Boost Retinol Repair Cream .
  • Dr. James Beckman, Founder of Theraderm Clinical Skincare, expresses his passion for the Brilliance Night Boost Retinol Repair Cream: "Our commitment to providing cutting-edge skincare solutions is at the heart of Theraderm.
  • The Brilliance Night Boost Retinol Repair Cream embodies our dedication to innovation and quality.
  • The Brilliance Night Boost Retinol Repair Cream is available on www.theraderm.net for $130.